Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial
Purpose. Survival following biochemical failure is highly variable. Using a randomized trial dataset, we sought to define a risk stratification scheme in men with locally advanced prostate cancer (LAPC). Methods. The TROG 96.01 trial randomized 802 men with LAPC to radiation ± neoadjuvant androgen s...
Saved in:
| Main Authors: | Allison Steigler, James W. Denham, David S. Lamb, Nigel A. Spry, David Joseph, John Matthews, Chris Atkinson, Sandra Turner, John North, David Christie, Keen-Hun Tai, Chris Wynne |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2012/814724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
by: Colin I Tang, et al.
Published: (2019-08-01) -
An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early‐Stage Follicular Lymphoma
by: Daniel Erku, et al.
Published: (2025-02-01) -
Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial – protocol for a phase II study
by: Paul Mitchell, et al.
Published: (2025-07-01) -
Sugarcane Cultivars Descriptive Fact Sheet: CP 96-1252, CP 01-1372 and CP 00-1101
by: Hardev Sandhu, et al.
Published: (2017-01-01) -
Sugarcane Cultivars Descriptive Fact Sheet: CP 96-1252, CP 01-1372 and CP 00-1101
by: Hardev Sandhu, et al.
Published: (2017-01-01)